Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Bals

Showing results (191-200 of 303) with videos related to

Pageof 31
Sort By:
ERJ Open Research|August 26, 2021
Long-term effect of α<sub>1</sub>-antitrypsin augmentation therapy on the decline of FEV<sub>1</sub> in deficient patients: an analysis of the AIR databaseIris G M Schouten, Marise J Kasteleyn, Roula Tsonaka, et al.
Respiratory Research|September 17, 2017
Cardiovascular risk in patients with alpha-1-antitrypsin deficiencySebastian Fähndrich, Frank Biertz, Annika Karch, et al.
JCI Insight|September 16, 2020
High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19David Schub, Verena Klemis, Sophie Schneitler, et al.
American Journal of Respiratory and Critical Care Medicine|October 23, 2015
Outcome of Patients with Interstitial Lung Disease Treated with Extracorporeal Membrane Oxygenation for Acute Respiratory FailureFranziska C Trudzinski, Franziska Kaestner, Hans-Joachim Schäfers, et al.
Scientific Reports|October 6, 2020
Micro-rheological properties of lung homogenates correlate with infection severity in a mouse model of Pseudomonas aeruginosa lung infectionXabier Murgia, Andreas M Kany, Christian Herr, et al.
Journal of Hepatology|March 25, 2018
Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patientsAlice M Turner, Jan Stolk, Robert Bals, et al.
Respiration; International Review of Thoracic Diseases|February 7, 2021
Prognostic Value of Oxygenated Hemoglobin Assessed during Acute Exacerbations of Chronic Pulmonary DiseaseClemens F Hinke, Rudolf A Jörres, Peter Alter, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 26, 2022
Injection of Recombinant Tissue Plasminogen Activator into Extracorporeal Membrane Oxygenators Postpones Oxygenator Exchange in COVID-19Sebastian Mang, Guy Danziger, Carlos Metz, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 21, 2024
Carbon Dioxide Targets in Extracorporeal Membrane Oxygenation for Acute Respiratory Distress SyndromeTorben M Rixecker, Vanessa Ast, Elianna Rodriguez, et al.
Therapeutic Advances in Respiratory Disease|November 8, 2023
Clinical factors linked to the type of respiratory medication in COPD: results from the COSYCONET cohortPeter Alter, Kathrin Kahnert, Franziska C Trudzinski, et al.
Pageof 31

Showing results (191-200 of 303) with videos related to

Sort By:
Pageof 31
ERJ Open Research|August 26, 2021
Long-term effect of α<sub>1</sub>-antitrypsin augmentation therapy on the decline of FEV<sub>1</sub> in deficient patients: an analysis of the AIR databaseIris G M Schouten, Marise J Kasteleyn, Roula Tsonaka, et al.
Respiratory Research|September 17, 2017
Cardiovascular risk in patients with alpha-1-antitrypsin deficiencySebastian Fähndrich, Frank Biertz, Annika Karch, et al.
JCI Insight|September 16, 2020
High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19David Schub, Verena Klemis, Sophie Schneitler, et al.
American Journal of Respiratory and Critical Care Medicine|October 23, 2015
Outcome of Patients with Interstitial Lung Disease Treated with Extracorporeal Membrane Oxygenation for Acute Respiratory FailureFranziska C Trudzinski, Franziska Kaestner, Hans-Joachim Schäfers, et al.
Scientific Reports|October 6, 2020
Micro-rheological properties of lung homogenates correlate with infection severity in a mouse model of Pseudomonas aeruginosa lung infectionXabier Murgia, Andreas M Kany, Christian Herr, et al.
Journal of Hepatology|March 25, 2018
Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patientsAlice M Turner, Jan Stolk, Robert Bals, et al.
Respiration; International Review of Thoracic Diseases|February 7, 2021
Prognostic Value of Oxygenated Hemoglobin Assessed during Acute Exacerbations of Chronic Pulmonary DiseaseClemens F Hinke, Rudolf A Jörres, Peter Alter, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 26, 2022
Injection of Recombinant Tissue Plasminogen Activator into Extracorporeal Membrane Oxygenators Postpones Oxygenator Exchange in COVID-19Sebastian Mang, Guy Danziger, Carlos Metz, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 21, 2024
Carbon Dioxide Targets in Extracorporeal Membrane Oxygenation for Acute Respiratory Distress SyndromeTorben M Rixecker, Vanessa Ast, Elianna Rodriguez, et al.
Therapeutic Advances in Respiratory Disease|November 8, 2023
Clinical factors linked to the type of respiratory medication in COPD: results from the COSYCONET cohortPeter Alter, Kathrin Kahnert, Franziska C Trudzinski, et al.
Pageof 31